Cargando…
A Case of Acute Liver Failure in a Patient on Isoniazid Prophylaxis for Latent Tuberculosis
Isoniazid (INH) is widely used for latent Mycobacterium tuberculosis despite the known risk of liver injury, with severe hepatitis occurring in up to 1% of patients. We report a patient who presented with two weeks of anorexia, nausea, and jaundice following six months of INH monotherapy for latent...
Autores principales: | Philipose, Jobin, Suchman, Kelly I, Aronsky, Danielle, Lee, Tai-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944168/ https://www.ncbi.nlm.nih.gov/pubmed/35345710 http://dx.doi.org/10.7759/cureus.22452 |
Ejemplares similares
-
Acute Liver Failure in a COVID-19 Patient Without any Preexisting Liver Disease
por: Gurala, Dhineshreddy, et al.
Publicado: (2020) -
Isoniazid-Induced Acute Liver Failure Requiring Liver Transplantation
por: Almeida, Mariana S, et al.
Publicado: (2022) -
Use of Isoniazid Monotherapy in Comparison to Rifamycin-Based Regimen for the Treatment of Patients With Latent Tuberculosis: A Systematic Review
por: Shahid, Noor ul ain, et al.
Publicado: (2022) -
Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area
por: Moon, Hyung Hwan, et al.
Publicado: (2017) -
Bouveret’s Syndrome
por: Philipose, Jobin, et al.
Publicado: (2019)